Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Centuria Industrial REIT - Dividend/Distribution (ASX:CIP)

To view the Notification of dividend / distribution, download the attached PDF.

Centuria Industrial REIT - June 2021 Distribution Declaration (ASX:CIP)

Centuria Industrial REIT (ASX: CIP) confirms that the distribution for the quarter ending 30 June 2021 will be 4.25 cents per unit. CIP’s Distribution Reinvestment Plan (DRP) will be activa...read more

Centuria Office REIT - June 2021 Distribution Declaration (ASX:COF)

Centuria Office REIT (ASX: COF), confirms that the distribution for the quarter ending 30 June 2021 will be 4.125 cents per unit. COF’s Distribution Reinvestment Plan (DRP) will be suspende...read more

Centuria Office REIT - Dividend/Distribution (ASX:COF)

To view the Notification of dividend / distribution, download the attached PDF.

Sequoia Financial Group - Change in substantial holding (ASX:SEQ)

To view the Notice of change of interest of substantial holder, download the attached PDF.

Immutep - Proposed issue of securities (ASX:IMM)

To view the proposed issue of securities, download the attached PDF.

Immutep - Efti to be evaluated in new triple combination therapy trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmun...read more

Immutep secures commitments for A$60 million in a Placement (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or Company), is pleased to announce that it has received commitments for a A$60 million via a two-tranche placement of new ordinary shares in Immute...read more

Immutep Capital Raising Presentation (ASX:IMM)

To view the presentation, download the attached PDF.

Centuria Capital Group - Change in Substantial Holder Notice from CNI (ASX:CNI)

Centuria Capital Group (Centuria or ASX:CNI) refers to its off market takeover bid (Centuria Offer) under Chapter 6 of the Corporations Act 2001 (Cth) (Corporations Act) to acquire all of the staple...read more

SUDA Pharmaceuticals - Investor Webinar (ASX:SUD)

SUDA Pharmaceuticals Ltd (ASX: SUD) is pleased to invite shareholders and interested parties to an investor webinar and Q&A hosted by CEO & Managing Director Dr Michael Baker. The webinar...read more

SUDA Pharmaceuticals - Investor Presentation incorporating iNKT Cell Platform (ASX:SUD)

To view the presentation, download the attached PDF.

SUDA Pharmaceuticals Licenses a Novel iNKT Cell Therapy Platform (ASX:SUD)

SUDA Pharmaceuticals Ltd (ASX: SUD), today announces that it has signed a global, exclusive Licence Agreement with Imperial College London for a novel invariant Natural Killer T (iNKT) cell therapy ...read more

SUDA Pharmaceuticals - Trading Halt (ASX:SUD)

The securities of Suda Pharmaceuticals Ltd (‘SUD’) will be placed in trading halt at the request of SUD, pending it releasing an announcement. Unless ASX decides otherwise, the securitie...read more